Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Recruiting · NCT07297979 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) | Disease Attributes, Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 1 | 2026-09-25 | NCT07297979 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | United States | 135 |
| Childrens Hospital Of Philadelphia | Philadelphia | United States | 18 |
| Chris Obrien Lifehouse | Camperdown | Australia | 17 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Johns Hopkins University | Baltimore | United States | 150 |
| Mayo Clinic Childrens Center | Rochester | United States | 2 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Perth Childrens Hospital | Nedlands | Australia | 2 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| University of California Los Angeles | Los Angeles | United States | 1 |
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |